Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05003609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation

Study acronym: ECMO-Rehab
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 10, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 7 of 7 sites
    v8
  2. Secondary endpoints: 11 to 14v7
  3. Primary and study completion dates: May 31, 2024 to May 30, 2025
    • Study sites: 3 to 7
    v6
  4. Phase: Phase 2 to Not applicablev5 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: May 31, 2023 to May 31, 2024
    • Study sites: 0 to 3
    • Start date changed from estimate of Apr 1, 2022 to Apr 27, 2022
    • Eligibility criteria expanded, about 28 words
  5. Start date: Dec 1, 2021 to Apr 1, 2022v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Oct 1, 2021 to Dec 1, 2021
    • Eligibility criteria expanded, about 18 words
    • Study title shortened, about 1 word
    v3
  2. Study description expanded, about 13 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This registry-embedded randomised trial aims to determine if early rehabilitation commenced within 72 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 100 ICU patients. The effect of the intervention on mortality, health status, and function at 180 days will be evaluated, as well as cost-effectiveness. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data.
Trial Details
NCT Number NCT05003609
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Collaborators: Monash University, National Health and Medical Research Council, Australia
Conditions
(from sponsor)		 Extracorporeal Membrane Oxygenation Complication
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov